Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 2/20 | 0.61 |
| ▸ | CA9 | Q16790 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | TACR1 | P25103 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1096291 | 1.00 | CA1 (0.61) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL2181772 | 1.00 | CA1 (0.61) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL12172300 | 0.90 | CA1 (0.51) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL872641 | 0.87 | CA1 (0.53) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL30405611 | 0.86 | CA1 (0.56) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL2781953 | 0.86 | CA1 (0.51) | CA1CA2CA7CA9KMT2A | |
| Isopropyl Alcohol SCHEMBL29076646 | 0.85 | TSHR (0.71) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL25032346 | 0.84 | KMT2A (0.62) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL12552888 | 0.84 | KMT2A (0.58) | CA1CA2CA7CA9KMT2A | |
| SCHEMBL9480893 | 0.84 | KMT2A (0.62) | CA1CA2CA7CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436153-B1 | — | — | None | — | — | US | claimed |
| US-20230295203-A1 | METAL ORGANIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2023-09-21 | — | — | US | claimed |
| US-20230192736-A1 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2023-06-22 | — | — | US | claimed |
| EP-4126889-A1 | METAL ORGANIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-02-08 | — | — | EP | claimed |
| EP-4126890-A1 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-02-08 | — | — | EP | claimed |
| CN-115315428-A | Metal organic compound | 优美科股份公司及两合公司 | 2022-11-08 | — | — | CN | claimed |
| CN-115244062-A | Metal organic compound | 优美科股份公司及两合公司 | 2022-10-25 | — | — | CN | claimed |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PSOMAGEN, INC. (US) | 2022-08-23 | — | — | US | claimed |
| US-11193079-B2 | Glycol ether neo-esters, lubricating oil compositions containing same and processes for making same | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2021-12-07 | — | — | US | claimed |
| US-20210128498-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | MACROGEN INC. (KR) | 2021-05-06 | — | — | US | claimed |
| US-6436153-B2 | FREE OF OXIDASES AND OXIDOREDUCTASES; HAIR DYE | L'ORéAL S.A. (FR) | 2002-08-20 | — | — | US | claimed |
| US-20020046431-A1 | Composition for the oxidation dyeing of keratinous fibers comprising at least one oxidation dye and at least one cationic amphiphilic polymer, and dyeing methods | LAURENT FLORENCE (FR) | 2002-04-25 | — | — | US | claimed |
| US-6371994-B2 | HAIR DYES | L'OREAL S.A. (FR) | 2002-04-16 | — | — | US | claimed |
| US-20020013971-A1 | OXIDATION DYEING COMPOSITION FOR KERATIN FIBRES | MAUBRU MIREILLE (FR) | 2002-02-07 | — | — | US | claimed |
| US-20020004955-A1 | DYE COMPOSITION FOR KERATIN FIBERS, WITH A CATIONIC DIRECT DYE AND A POLYOL OR POLYOL ETHER | L' OREAL S.A. | 2002-01-17 | — | — | US | claimed |
| US-20020002748-A1 | COMPOSITION FOR THE DIRECT DYEING OF KERATIN FIBRES WITH A CATIONIC DIRECT DYE AND A POLYOL AND/OR A POLYOL ETHER | L'OREAL S.A. | 2002-01-10 | — | — | US | claimed |
| WO-2001094513-A1 | BIOCIDAL CLEANER COMPOSITION | S. C. JOHNSON & SON, INC. (US) | 2001-12-13 | — | — | WO | claimed |
| EP-0572910-B1 | Polysaccharide ether dialysis membrane | AKZO NOBEL NV (NL) | 1996-06-26 | — | — | EP | claimed |
| US-5427684-A | Biocompatibility; damage to blood cells minimized | AKZO NV (NL) | 1995-06-27 | — | — | US | claimed |
| EP-0572910-A1 | Polysaccharide ether dialysis membrane | Akzo Nobel N.V. (NL) | 1993-12-08 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295203-A1 | METAL ORGANIC COMPOUNDS | SCO2, MLX, PYM1 | CA1 904/4885CA2 489/4885CA7 351/4885 |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PNMT, MAOA, HNMT | CA1 1029/4885CA2 483/4885CA7 434/4885 |
| US-20210128498-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | MAOA, PNMT, HNMT | CA1 307/4885CA2 161/4885CA7 171/4885 |
| US-20020013971-A1 | OXIDATION DYEING COMPOSITION FOR KERATIN FIBRES | KRT18, COX6C, MT-CO1 | CA1 1166/4885CA2 1137/4885CA7 299/4885 |
| US-11193079-B2 | Glycol ether neo-esters, lubricating oil compositions containing same and processes for making same | ELOVL5, ELOVL1, NAPEPLD | CA1 2792/4885CA2 4715/4885CA7 1777/4885 |
| US-20020004955-A1 | DYE COMPOSITION FOR KERATIN FIBERS, WITH A CATIONIC DIRECT DYE AND A POLYOL OR POLYOL ETHER | KRT18, KRTCAP2, DSG1 | CA1 3004/4885CA2 2465/4885CA7 615/4885 |
| US-20020002748-A1 | COMPOSITION FOR THE DIRECT DYEING OF KERATIN FIBRES WITH A CATIONIC DIRECT DYE AND A POLYOL AND/OR A POLYOL ETHER | KRT18, COXFA4L2, CKMT1A; CKMT1B | CA1 1479/4885CA2 1788/4885CA7 536/4885 |
| US-20020046431-A1 | Composition for the oxidation dyeing of keratinous fibers comprising at least one oxidation dye and at least one cationic amphiphilic polymer, and dyeing methods | KRT18, ACAD10, OAT | CA1 2759/4885CA2 2589/4885CA7 1035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.